BioWorld Science

June 20, 2017

View Archived Issues

Novel pocket-modified vancomycin analogues show potential as durable and potent antibiotics

Read More

Mutations in SCN9A gene linked to diabetic neuropathic pain

Read More

FDA accepts Rigel Pharmaceuticals' NDA for fostamatinib disodium

Read More

Axovant Sciences' nelotanserin obtains FDA fast track designation

Read More

Seattle Genetics halting phase III CASCADE study of vadastuximab talirine

Read More

Human umbilical cord mesenchymal stem cells evaluated in ischemic cardiomyopathy trial

Read More

EC approves biosimilar rituximab from Sandoz

Read More

Next generation diarylquinoline TBAJ-587 displays superior potency against tuberculosis

Read More

MedImmune introduces a novel anti-FcRII-a antibody

Read More

Engineered grafts show esophageal regeneration ability in a large animal model

Read More

Tessa Therapeutics enters alliance with Parker Institute for Cancer Immunotherapy

Read More

Cell Medica acquires Catapult Therapy TCR

Read More

Abide Therapeutics describes novel MGL/FAAH inhibitors

Read More

FDA approves Baxdela for ABSSSI

Read More

eFFECTOR Therapeutics identifies new MAP kinase signal-integrating kinase 1/2 inhibitors

Read More

Novel USP1 inhibitors identified at FORMA Therapeutics

Read More

Clovis Oncology presents positive topline data from phase III ARIEL3 study of rucaparib

Read More

ViiV Healthcare presents novel anti-HIV compounds

Read More

AstraZeneca, Cancer Research Technology patent GLS inhibitors

Read More

Narurapid and Narusus launched in Japan

Read More

Enzychem Lifesciences begins phase II trial of EC-18 in CIN

Read More

Novartis reports phase III data on RTH-258 in neovascular AMD

Read More